Logo image of EVGN

EVOGENE LTD (EVGN) Stock Analyst Earnings Estimates

NASDAQ:EVGN - Nasdaq - IL0011050551 - Common Stock - Currency: USD

1.48  +0.07 (+4.94%)

Premarket: 1.47 -0.01 (-0.68%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
EVGN revenue by date.EVGN revenue by date.
930K
-10.58%
1.68M
80.65%
5.64M
235.71%
10.736M
90.35%
14.892M
38.71%
26.546M
78.26%
EBITDA
YoY % growth
EVGN ebitda by date.EVGN ebitda by date.
-28.63M
-29.66%
-27.74M
3.11%
-23.912M
13.80%
-17.034M
28.76%
-17.862M
-4.86%
-12.576M
29.59%
EBIT
YoY % growth
EVGN ebit by date.EVGN ebit by date.
-30.86M
-24.39%
-30.32M
1.75%
-26.524M
12.52%
-23.574M
11.12%
-22.86M
3.03%
-18.518M
19.00%
Operating Margin
EVGN operating margin by date.EVGN operating margin by date.
-3,318.28%-1,804.76%-470.28%-219.58%-153.51%-69.76%
EPS
YoY % growth
EVGN eps by date.EVGN eps by date.
-6.90
17.50%
-6.40
7.25%
-5.30
17.19%
-4.20
41.32%
-3.17
-2.00%
-2.24
29.26%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.74
6.93%
-0.90
15.32%
-0.81
38.49%
-0.63
-1,154.00%
Revenue
Q2Q % growth
4.08M
-2.63%
1.53M
67.40%
2.55M
41.98%
5.1M
216.77%
EBITDA
Q2Q % growth
-4.182M
-44.41%
-5.33M
-10.73%
-4.743M
14.45%
-3.596M
18.38%
EBIT
Q2Q % growth
-5.661M
-58.70%
-6.809M
-11.67%
-6.222M
16.54%
-5.075M
9.03%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
0.06
104.62%
-0.740.80108.11%
Q3 2024
Q2Q % growth
-1.31
-63.75%
-1.03-0.28-27.16%
Q2 2024
Q2Q % growth
-1.06
37.65%
-1.280.2116.86%
Q1 2024
Q2Q % growth
-0.80
46.67%
-0.970.1717.44%
Q4 2023
Q2Q % growth
-1.30
-85.71%
-1.430.138.96%
Q3 2023
Q2Q % growth
-0.80
50.00%
-1.600.8049.94%
Q2 2023
Q2Q % growth
-1.70
19.05%
-1.790.094.76%
Q1 2023
Q2Q % growth
-1.50
25.00%
-1.630.138.09%
Q4 2022
Q2Q % growth
-0.70
61.11%
-2.041.3465.69%
Q3 2022
Q2Q % growth
-1.60
15.79%
-2.040.4421.57%
Q2 2022
Q2Q % growth
-2.10
-40.00%
-1.84-0.26-14.38%
Q1 2022
Q2Q % growth
-2.00
-17.65%
-1.79-0.21-12.04%
Q4 2021
Q2Q % growth
-1.80
28.00%
-2.090.2913.92%
Q3 2021
Q2Q % growth
-1.90 -1.73-0.17-9.57%
Q2 2021
Q2Q % growth
-1.50 -1.840.3418.30%
Q1 2021
Q2Q % growth
-1.70 -1.840.147.41%
Q4 2020
Q2Q % growth
-2.50 -1.73-0.77-44.18%
EVGN Yearly EPS VS EstimatesEVGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -2 -4 -6 -8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
1.61M
178.55%
3.698M-2.088M-56.46%
Q3 2024
Q2Q % growth
1.796M
-52.32%
2.907M-1.111M-38.22%
Q2 2024
Q2Q % growth
914K
39.76%
816K98K12.01%
Q1 2024
Q2Q % growth
4.19M
553.67%
3.57M620K17.37%
Q4 2023
Q2Q % growth
578K
-12.42%
510K68K13.33%
Q3 2023
Q2Q % growth
3.767M
701.49%
1.204M2.563M212.87%
Q2 2023
Q2Q % growth
654K
110.97%
902.7K-248.7K-27.55%
Q1 2023
Q2Q % growth
641K
167.08%
887.4K-246.4K-27.77%
Q4 2022
Q2Q % growth
660K
112.90%
433.5K226.5K52.25%
Q3 2022
Q2Q % growth
470K
213.33%
102K368K360.78%
Q2 2022
Q2Q % growth
310K
121.43%
102K208K203.92%
Q1 2022
Q2Q % growth
240K
-27.27%
306K-66K-21.57%
Q4 2021
Q2Q % growth
310K
-11.43%
204K106K51.96%
Q3 2021
Q2Q % growth
150K
-53.13%
275.4K-125.4K-45.53%
Q2 2021
Q2Q % growth
140K
-53.33%
306K-166K-54.25%
Q1 2021
Q2Q % growth
330K
312.50%
306K24K7.84%
Q4 2020
Q2Q % growth
350K
191.67%
350K%
Q3 2020
Q2Q % growth
320K
220.00%
%
Q2 2020
Q2Q % growth
300K
57.89%
%
Q1 2020
Q2Q % growth
80K
-77.14%
%
EVGN Yearly Revenue VS EstimatesEVGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 2.03% 0% -12.89%
Revenue0% 0% 0% -17.46%